Pfizer expects to seek authorization for COVID-19 vaccine for younger kids in September

Pfizer expects to be able to submit its COVID-19 vaccine to the FDA for emergency use authorization in children as young as age 2 years in September, Chairman and CEO Albert Bourla, DVM, PhD, said Tuesday. By then, the company will have results from ongoing trials being conducted in young children and will be able to submit to the FDA for an emergency use authorization (EUA) in children aged 2 to

Read the full article here

Related Articles